The effects of bilateral carotid artery occlu sion/recirculation on cortical CBF (cCBF) were studied in rats following the intravenous administration of either the nitric oxide synthase inhibitor �-nitro-L-arginine methyl ester hydrochloride (L-NAME; 30 mg/kg) or an equiva lent volume of saline (500 fLl). Induction of bilateral ca rotid occlusion (BCO) in L-NAME-treated animals re sulted in a reduction of cCBF to 30% of baseline. During recirculation subsequent to 20 min of BCO, cCBF in An important intrinsic mechanism for limiting cellular damage following cerebral ischemia is that of collateral channel activation (Chen et aI., 1986; Coyle, 1986; Brint et aI., 1988; Hossmann, 1988) .
L-NAME-infused animals remained at 30% of baseline. In contrast, cCBF in saline-treated control animals returned to the original baseline level following a similar reduction to 30-40% of baseline during BCO. These results indicate that inhibition of nitric oxide generation limits normaliza tion of regional cortical perfusion following occlusion of proximal large cerebral vessels. Key Words: Cerebral blood flow-Cerebral ischemia-Endothelium-derived relaxing factor-Nitric oxide synthase inhibitor.
Indeed, experimentally induced cerebral ischemia! recirculation (Mayhan et aI., 1988) has been shown to destroy NO and abolish endothelium-mediated dilation of cerebral arterioles in response to acetyl choline.
These studies suggest that NO synthesis is vital in regulating the hemodynamics of the circulation un der normal and pathological conditions. We hypoth esize that endogenous secretion of NO is critical in preserving the collateral vasodilator response to ce rebrovascular occlusion/recirculation. The aims of this study were therefore to determine whether the changes in cortical CBF (cCBF; measured by laser Doppler flowmetry) produced by bilateral tempo rary occlusion of the common carotid arteries (BCO) and recirculation are influenced by basal ni tric oxide production.
MATERIALS AND METHODS
Food-deprived male Wi star rats (n = 14; 250-350 g) were anesthetized with 4% halothane and maintained on a 70:30 mixture of N 2 0/0 2 and 0.5% halothane delivered via an endotracheal tube (PE-240). Femoral venous and arterial catheters (PE-50) were inserted for fluid adminis tration, blood gas determination, and blood pressure monitoring. Ligatures consisting of a loop of PE-10 tubing contained within a double-barreled Silastic tubing were placed around each common carotid artery. The rats were mechanically ventilated with a small animal respirator af ter muscle paralysis with pancuronium bromide 0.35 mg/ kg i. v., followed by 0. 1 mg/kg every half-hour for main tenance.
A 3-mm 2 burr hole was made over the right frontopa rietal cortex -1.3 mm posterior and 5.5 mm lateral to bregma, and cCBF was measured by means of a laser Doppler blood perfusion monitor (Prado et aI., 1992) . The rats were divided into two groups. In one group (n = 8), a 0.9% saline solution of ,vG-nitro-L-arginine methyl ester hydrochloride (L-NAME; Sigma, St. Louis, MO, U.S.A.) was administered over a 5-min period as a single intrave nous dose of 30 mg/kg. The choice of L-NAME as an in vivo inhibitor of nitric oxide synthase was dictated by its previous characterization as an NO synthesis inhibitor (Rees et aI., 1990) . Inhibition has been shown both in vitro and in vivo in the dose range we used, and its re versibility by L-arginine hydrochloride has been demon strated. In a second group (n = 6), an equivalent volume of 0.9% saline was administered intravenously at an equivalent rate. To reduce CBF in the forebrain, the lig atures around the carotid arteries were tightened (BCO) for 20 min without inducing hypotension. To permit re circulation, both carotid ligatures were removed.
Following a I-h equilibration period, baseline cCBF and MABP were measured and averaged over a I-h pe riod. Measurements of cCBF and MABP were carried out at 5 and 10 min after beginning the intravenous infusion of L-NAME (30 mg/kg) or saline; at 5, 15, and 20 min after the induction of BCO; and at 5, 15, 30, and 60 min after the onset of recirculation. Measurements of cCBF and MABP are each expressed graphically as a percentage of baseline values (mean ± SD). Comparisons of cCBF or MABP between baseline values and subsequent data with either L-NAME or saline were assessed by the SYSTAT program, employing analysis of variances (ANOVA) with post hoc tests (Wilkinson, 1989) . When mUltiple compar isons were made, a Bonferroni correction was applied; a p value of <0.01 was considered significant.
RESULTS
Physiological variables are presented in Table 1 .
No significant differences were seen between the L-NAME-treated and saline-treated groups. In the saline-treated control group, no significant differ ences in MABP from baseline (98.3 ± 8.8 mm Hg) Values are means ± SD, with animals at 37cC. L-NAME, N" nitro-L-arginine methyl ester hydrochloride.
a Samples taken 15 min into the recirculation period. (Fig. 2) and was also significantly de creased with respect to the level observed during BCO (cf. Fig. 1 ) (F = 67.9, p < 0.001, recirculation vs. occlusion). cCBF decreased significantly after infusion of L-NAME (F = 7.07, p < 0.0 1) ( Fig. 1) and was further reduced during BCO (F = 53.2, p < 0.001) (Fig. 2) . During recirculation, cCBF differed from baseline (F = 69.4, p < 0.00 1) (Fig. 2) but remained essentially unchanged compared with cCBF during BCO (F = 0. 10, NS) ( Fig. 1) , and recirculation. MABP and cCBF are expressed as mean ± SD percentage of baseline. a, significantly different from baseline values (p < 0.01); b, significantly different from val ues during BCO (p < 0.001); c, significantly different from recordings after L-NAME infusion (B') (p < 0.001); d, signif icantly different from values during recirculation after saline infusion as presented in Fig. 1 (p < 0.001) . Dashed line des ignates the period of variable hyperemic response during the initial phase of recirculation (see Results for values).
baseline in three of eight L-NAME-infused rats.
When comparing cCBF in L-NAME-and saline treated animals, similar reductions in cCBF were seen during BCO (F = 2.96, NS), whereas a highly significant difference was seen during the recircula tion period (F = 89.8, p < 0. 00 1).
DISCUSSION
A comparable reduction in local tissue perfusion was observed in both groups during BCO despite the fact that MABP during this period was signifi cantly higher in the L-NAME-treated group than in saline-treated animals. This finding suggests that cerebrovascular resistance during BCO was ele vated (with respect to saline-treated rats) by L-NAME treatment.
Severe reductions in CBF are usually followed in the postischemic period by a characteristic hyper emic phase that increases in duration as a function of the length of ischemia (Gourley and Heistad, 1984; Todd et aI., 1986) . Luscher et aI. , 1989) . Thus, if production and release of NO from the cerebral vas cular endothelium were disturbed, it could be sur mised that challenging an already pathologically compromised vascular network (Prado et aI., 1992) with occlusion of a major conduit artery would worsen hemodynamic outcome.
In conclusion, our findings demonstrate that the cerebral vascular response following large vessel occlusion is altered fundamentally as a conse quence of artificially inhibiting NO synthase.
Therefore, while altering vascular tone under phys iological and pathophysiological conditions, inhibi tion of NO synthase may simultaneously override counter balancing pathways which contribute to the regulation of blood flow in the cerebral circulation.
